Warren Shawn Carbonell

Chief Scientific Officer

2022 - Current

Cofounder & Managing Partner

2021

Academia sucks. Start a startup. Funding the rising generation of scientist-CEOs.

Cofounder & CEO

2021

Building community for the rising generation of scientist-CEOs

Cofounder & President

2019

Building awareness and solutions for brain cancer.

Cofounder & CEO

2011 - 2019

Inventor and developer of the first ever clinical stage beta1 integrin therapeutic, OS2966.

Postdoctoral Scholar, Department of Neurological Surgery

2010 - 2012

Studied the role of CD29 in driving therapy resistance in glioblastoma, @Brain Tumor Research Center (BTRC)

Nicholas Kurti Junior Fellow in Science

2007 - 2010

Demonstrated the key role of CD29 in the establishment and progression of brain metastases.

Senior Postdoctoral Fellow

2006 - 2009

Senior Postdoctoral Researcher supported by Cancer Research UK. Established and was a lead investigator of the brain metastasis research program in the Department of Radiation Oncology and Biology at the University of Oxford, UK.

Neurosurgery Resident

2009 - 2009

Medical Student (MSTP)

1999 - 2006

Dean's Merit Scholar of the Medical Scientist Training Program (MD/PhD).

Graduate Researcher (MSTP)

2000 - 2005

PhD student in the Department of Neuroscience through the UVA Medical Scientist Training Program (MSTP). Research focus: neuroinflammation in disease states and injury. Analysis of cell migration in the brain.

Undergraduate Researcher

1995 - 1999

Researcher in the Department of Neurological Surgery. Research focus: traumatic brain injury.